Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic pacing lead

This article was originally published in The Gray Sheet

Executive Summary

Firm launches the SelectSecure pacing lead in the U.S. after receiving premarket approval Aug. 3. SelectSecure is the "world's thinnest bipolar lead" and the first allowing selective lead placement in the right atrium or right ventricle, away from the apex of the ventricle, according to the firm. Medtronic says that right-side leads have traditionally been affixed near the apex because it was the easiest site to access, but that new research suggests this may cause the two chambers of the heart to beat disjointedly, potentially leading to atrial fibrillation...
Advertisement

Related Content

Chart: FDA August 2005 Report of Medical Device Approvals
Advertisement
UsernamePublicRestriction

Register

MT022583

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel